1. P1141: IBRUTINIB AND RITUXIMAB AS FIRST LINE THERAPY FOR MANTLE CELL LYMPHOMA: A MULTICENTRE, REAL-WORLD UK STUDY. (23rd June 2022) Authors: Tivey, A.; Shotton, R.; Eyre, T. A.; Lewis, D.; Crosbie, N.; Nga, E.; Guerrero Camacho, R.; Swe, W.; Marr, H.; Rees, C.; Moule, S.; Sutton, T.; Wrench, D.; Thomas, N.; Wilson, M.; Bailey, J.; Prahladan, M.; Hodson, A.; Koppana, M.; Smith, S. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1031 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗